Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology
Volume 25, Issue 9, Pages 503-510
http://dx.doi.org/10.1155/2011/698780
Original Article

Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)

Robert P Myers,1 Curtis Cooper,2 Morris Sherman,3 Richard Lalonde,4 Helga Witt-Sullivan,5 Magdy Elkashab,6 Paul Harris,7 Rob Balshaw,8 Christopher Usaty,9 and Paul J Marotta10

1Liver Unit, University of Calgary, Calgary, Alberta, Canada
2University of Ottawa, Ottawa, Canada
3University Health Network, Toronto, Ontario, Canada
4McGill University, Montreal, Quebec, Canada
5McMaster University, Hamilton, Canada
6Toronto Liver Centre, Toronto, Ontario, Canada
7University of Saskatchewan, Saskatoon, Saskatchewan, Canada
8Syreon Corporation, Vancouver, British Columbia, Canada
9Hoffmann-La Roche Ltd, Mississauga, Canada
10University of Western Ontario, London, Ontario, Canada

Received 6 May 2011; Accepted 4 June 2011

Copyright © 2011 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Robert P Myers, Curtis Cooper, Morris Sherman, et al., “Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada),” Canadian Journal of Gastroenterology, vol. 25, no. 9, pp. 503-510, 2011. https://doi.org/10.1155/2011/698780.